InvestorsHub Logo
Followers 29
Posts 720
Boards Moderated 0
Alias Born 01/22/2014

Re: Canadian Trader post# 2280

Tuesday, 09/16/2014 12:52:55 PM

Tuesday, September 16, 2014 12:52:55 PM

Post# of 118425
SUMMARY OF DCELLVAX PROGRESS (UPDATED SEPT 2014):

Feb 26, 2013 - BMSN announce Letter of Intent (LOI) to acquire WP Min cancer gene-silencing intellectual property.
http://ih.advfn.com/p.php?pid=nmona&article=56463068

Apr 4, 2013 - Update about pre-clinical and clinical programs; planned IND submission for Q4 2013.
http://ih.advfn.com/p.php?pid=nmona&article=57035344

May 6, 2013 - Regen officially acquires WP Min cancer gene-silencing therapy patent; will focus efforts on breast cancer.
http://ih.advfn.com/p.php?pid=nmona&article=57439657

Aug 8, 2013 - Regen licenses cancer gene-silencing therapy from Benitec BioPharma; demonstrates its action on IDO in dendritic cells.
http://ih.advfn.com/p.php?pid=nmona&article=58739425

Aug 16, 2013 - Conducting toxicity experiments using WP Min and Benitec technologies; reiterates planned submission of IND by Q4 2013.
http://ih.advfn.com/p.php?pid=nmona&article=58853168

Sept 17, 2013 - BMSN recruit Dr. David Suhy to Regen advisory board; his experience in RNAi is useful for Regen's cancer therapy.
http://ih.advfn.com/p.php?pid=nmona&article=59244933

Sept 25, 2013 - Announcement of "dCellVax" breast cancer immunotherapeutic product; outline further 8 months of milestones.
http://ih.advfn.com/p.php?pid=nmona&article=59354656

Jun 11, 2014 - Announce research paper on the use of gene-silencing in heart transplants, showing multiple applications of dCellVax technology; dCellVax IND planned for August 2014.
http://ih.advfn.com/p.php?pid=nmona&article=62529632

Aug 1, 2014 - Update on dCellVax progress; Regen successfully achieves silencing of the IDO gene in human dendritic cells ahead of expected IND submission.
http://www.marketwatch.com/story/regen-biopharma-provides-update-on-dcellvax-breast-cancer-immunotherapy-2014-08-01

Sept 16, 2014 - Regen announce patent filing for novel means of cancer immunotherapy; basis of dCellVax.
http://www.marketwatch.com/story/regen-biopharma-files-patent-application-on-new-therapy-that-uses-the-innate-immune-system-to-kill-cancer-2014-09-16

** All dates listed above refer to the date of the linked PR **


For further Regen BioPharma timelines, please see my post on HemaXellerate I progress: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=106166628

$$ RGBP smile BMSN $$